Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.
Journal: Nature reviews. Urology
Published: June 04, 2026
Targeting Myeloid Cells for Cancer Immunotherapy.
Journal: Cancer immunology research
Published: April 01, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer.
Journal: Cancer cell
Published: October 10, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.
Journal: Research square
Published: June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.
Journal: medRxiv : the preprint server for health sciences
Published: June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.
Journal: The Journal of clinical investigation
Published: February 22, 2024
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.
Journal: Cancer immunology research
Published: May 21, 2023
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions.
Journal: Cancer cell
Published: April 21, 2023
Beyond T Cells: IgA Incites Immune Recognition in Endometrial Cancer.
Journal: Cancer research
Published: December 21, 2021
Deciphering radiological stable disease to immune checkpoint inhibitors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 18, 2021
Last Updated: 09/26/2026